. 2014 Sep 18;14:406. doi: 10.1186/1472-6963-14-406

Table 3.

Medication Appropriateness Index (MAI) by study group

	Enhanced	Minimal	Control	P-values ^*
Summed MAI per Participant
Discharge	7.1 (±7.0)	8.0 (±8.4)	6.1 (±6.6)	E + M vs. C: 0.03
30 days post-discharge	10.1 (±8.9)	11.7 (±11.2)	9.6 (±9.5)	E vs. C: 0.78
30 days post-discharge	10.1 (±8.9)	11.7 (±11.2)	9.6 (±9.5)	M vs. C: 0.07
90 days post-discharge	11.6 (±10.5)	13.6 (±12.3)	11.1 (±11.3)	E vs. C: 0.94
90 days post-discharge	11.6 (±10.5)	13.6 (±12.3)	11.1 (±11.3)	M vs. C: 0.02
MAI per Medication
Discharge	0.52 (±0.53)	0.55 (±0.57)	0.51 (±0.54)	E + M vs. C: 0.26
30 days post-discharge	0.62 (±0.50)	0.69 (±0.61)	0.65 (±0.57)	E vs. C: 0.86
30 days post-discharge	0.62 (±0.50)	0.69 (±0.61)	0.65 (±0.57)	M vs. C: 0.70
90 days post-discharge	0.72 (±0.68)	0.80 (±0.65)	0.73 (±0.63)	E vs. C: 0.84
				M vs. C: 0.33

*E = enhanced, M = minimal and C = control groups.